MedPath

Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System

Completed
Conditions
Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic Arthritis
Registration Number
NCT01469299
Lead Sponsor
Orthosensor, Inc.
Brief Summary

The primary objectives of this evaluation are: 1) To attempt to refine the current clinical understanding of "balance" 2) To determine if patients with quantifiably balanced knee joints exhibit improved clinical outcomes versus patient with residual imbalance, as measured by the VERASENSE™ Knee System

Secondary objectives:

* Determine whether a difference in inter-compartment loads and soft tissue tension exists between the physicians intra-operative feel compared to the quantifiable data measured by the VERASENSE™ Knee System

* Determine which ligament releases are performed by the surgeon to improve soft tissue balance while utilizing the information from the VERASENSE™ Knee System

* Evaluate range of motion, pain, physical function, activity level, and patient satisfaction between baseline (pre-operative) and post-operative follow-up as well as radiographic success and survivorship of the knee implants

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
285
Inclusion Criteria
  • Subject must be a candidate for a primary total knee replacement
  • Subject must be diagnosed with one or more of the following conditions: osteoarthritis, avascular necrosis, rheumatoid or other inflammatory arthritis post-traumatic arthritis
  • Subject's joint must be anatomically and functionally suited to receive the selected implant
  • Subject is 50 years of age or older (≥ 50 yrs) at the time of consent
  • Subject is likely to be available for all study visits
  • Subject is able and willing to sign the informed consent and follow study procedures
  • Subject is not pregnant
Exclusion Criteria
  • Prior total knee arthroplasty
  • Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease)
  • Subject is pregnant
  • Subject has an active infection or joint sepsis
  • Subject has muscular, neurological or vascular deficiencies which compromise the affected extremity (i.e., Parkinson's Disease, Multiple Sclerosis, and Charcot joints)
  • Ligament insufficiencies, prior surgeries such as ACL or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures
  • Range of Motion less than 90 degrees, flexion contracture of more than 20 degrees

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Joint BalanceAt time of Total Knee Surgery
Secondary Outcome Measures
NameTimeMethod
Patient Reported Outcome MeasuresChanges from Baseline at 3-years

Trial Locations

Locations (8)

St. Helena Hospital

🇺🇸

St. Helena, California, United States

Holy Cross Orthopedic Institute

🇺🇸

Fort Lauderdale, Florida, United States

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

Tampa General/FORE

🇺🇸

Tampa, Florida, United States

Spectrum Health/Orthopaedic Associates of Michigan

🇺🇸

Grand Rapids, Michigan, United States

Trinity Health/Bone and Joint Institute

🇺🇸

Port Huron, Michigan, United States

Emory Healthcare - St. Joseph's Research Institute

🇺🇸

Atlanta, Georgia, United States

Naples Community Hospital

🇺🇸

Naples, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath